The Food and Drug Administration (FDA) confirmed that RIOMET, a metformin hydrochloride oral solution, was not taken off the market for safety or effectiveness issues. This finding means that the FDA can continue approving generic versions of this medication if they meet legal requirements. RIOMET is listed as discontinued in the FDA's "Orange Book," but this is not due to any safety concerns. As a result, companies can still seek approval to produce generic versions of RIOMET, provided they comply with all necessary regulations.
Simple Explanation
The FDA says that a type of liquid medicine called RIOMET, which helps control blood sugar, was not taken off shelves because it was dangerous or didn't work. This means that other companies can make and sell this medicine too, as long as they follow the rules.